Use of a genetically engineered E. coli overexpressing β-glucuronidase accompanied by glycyrrhizic acid, a natural and anti-inflammatory agent, for directed treatment of colon carcinoma in a mouse model
| Image |  |
|---|---|
| Description | scientific article published on 17 February 2020 |
| Author/s |
author: Maryam Moghaddam Matin |
| Publication date | February 17, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |